Labcorp Holdings Inc. logo
Labcorp Holdings Inc. (LH)
Compare

Labcorp Holdings Inc. (LH) Performance:2.80%(TTM)

Stocks/LH Stock/Performance
Compare

The total return for Labcorp Holdings Inc. (LH) stock is +2.80% over the past 12 months vs. +24.28% for the S&P 500. So far it's up +6.65% this year. Includes price appreciation + reinvested dividends.

|||

Labcorp Holdings Inc. (LH) Compound Annual Growth Rates (CAGR) Summary

Category1Y (TTM)3Y5Y10Y15Y20Y
Price CAGR+1.72%+11.33%+3.68%+9.04%+8.15%+8.54%
Total Return CAGR+2.80%+12.68%+4.75%+9.60%+8.53%+8.82%
Revenue CAGR+7.34%+4.20%(1.58%)+4.33%+6.93%+7.38%
Net Income CAGR+28.83%(2.00%)(18.65%)+4.69%+3.62%+4.49%
EPS CAGR+18.57%(9.11%)(8.00%)+9.08%+4.49%+6.68%
Free Cash Flow CAGR+20.14%+3.11%(12.63%)+4.41%+4.30%+5.13%
Operating Cash Flow CAGR+10.98%+1.76%(10.11%)+4.28%+5.04%+5.70%
Dividends CAGR0.00%+15.78%+9.52%+9.52%+9.52%+9.52%

CAGR Trends History

Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.

Select Metric:

LH Total Return CAGR Chart

Labcorp Holdings Inc. (LH)

Annual Total Returns Comparison

YearStart ValueEnd ValueLH ReturnSPY ReturnOutperformance
2026(YTD)1460.261557.35+6.65%+9.08%(2.43%)
20251320.021460.26+10.62%+17.72%(7.10%)
20241291.341320.02+2.22%+24.89%(22.67%)
20231134.341291.34+13.84%+26.19%(12.35%)
20221500.441134.34(24.40%)(18.17%)(6.23%)
2021971.981500.44+54.37%+28.74%+25.63%
2020807.84971.98+20.32%+18.37%+1.95%
2019603.39807.84+33.88%+31.22%+2.66%
2018761.70603.39(20.78%)(4.56%)(16.22%)
2017613.06761.70+24.25%+21.70%+2.55%
Last Precomputed Sync: Sunday, June 14, 2026

About Labcorp Holdings Inc.

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Burlington, NC
60,900 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Adam H. Schechter